NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Procavea Biotech

Procavea Biotech

Private
ZurichHealthcare & Life Scienceshttps://www.procavea.com/

Last Round

Seed

Jun 1, 2024

Total Funding Raised

$343,000

Company Overview

Procavea Biotech is a biotechnology company that develops a proprietary protein-based drug delivery platform for RNA therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

drug delivery platformRNA therapeuticssiRNARNA deliveryprotein cagetargeted deliveryextrahepatic deliveryRNAibiotech licensingcomputational protein designnon-viral deliverydrug delivery techbiotech startupnanomedicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Procavea Biotech Comparables

Compare Procavea Biotech with similar companies based on industry and business-model similarity.

Procavea Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vivatides Therapeutics
81%
Mana.bio
79%
Aanastra Inc.
78%

Procavea Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 1, 2024
AcceleratorDec 27, 2023
GrantOct 31, 2023

Key People

Founding team and executive leadership

Tom Edwardson

Chief Scientific Officer, Founder

Founding Team

Richard Quaderer

Co-Founder & CEO

Founding Team

Procavea Biotech Investors

Notable investors and investment history

Procavea Biotech investors
InvestorRounds
Gebert Rüf StiftungGrant
KickfundSeed
Venture KickAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 1, 2024

    Seed round raised with Kickfund as an investor.

  • Oct 31, 2023

    $165K grant received from Gebert Rüf Stiftung.

Procavea Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Procavea Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Procavea Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersZurich
Employee Range2
Year Founded2024
Last FundingJun 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.